Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,468 | -1,100,642 | -1,044,316 | -894,040 | -24,982 |
| Depreciation Amortization | 61,742 | 214,524 | 291,040 | 226,941 | 42,902 |
| Income taxes - deferred | 2,571 | -17,887 | -53,762 | -12,308 | -4,395 |
| Accounts receivable | -7,796 | 122,363 | 111,500 | 141,875 | 4,745 |
| Accounts payable and accrued liabilities | 8,775 | 6,478 | -10,680 | 145,324 | 16,124 |
| Other Working Capital | -58,923 | 65,943 | -144,045 | 21,322 | -2,688 |
| Other Operating Activity | -49,978 | 607,431 | 680,287 | 373,430 | -66,772 |
| Operating Cash Flow | $-50,077 | $-101,790 | $-169,976 | $2,544 | $-35,066 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 54,769 | -112,988 | -124,454 | -88,572 | -28,909 |
| Net Acquisitions | N/A | 324,260 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -844 | -10,369 | -14,217 | -10,635 | -2,329 |
| Other Investing Activity | -844 | -66,849 | -16,127 | -12,545 | -19,291 |
| Investing Cash Flow | $53,925 | $144,423 | $-140,581 | $-101,117 | $-48,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 269,100 | 2,914,784 | N/A | N/A | 776,984 |
| Debt Issued | N/A | N/A | 2,442,484 | 1,630,184 | N/A |
| Debt Repayment | N/A | N/A | -2,171,784 | -1,495,184 | N/A |
| Common Stock Repurchased | 0 | -10,179 | -6,656 | -6,656 | -1,503 |
| Other Financing Activity | -218,016 | -2,716,527 | 41,530 | -3,867 | -682,703 |
| Financing Cash Flow | $51,084 | $188,078 | $305,574 | $124,477 | $92,778 |
| Exchange Rate Effect | -41 | 1,896 | 1,767 | 1,801 | 542 |
| Beginning Cash Position | 281,989 | 49,382 | 49,382 | 49,382 | 49,382 |
| End Cash Position | 336,880 | 281,989 | 46,166 | 77,087 | 59,436 |
| Net Cash Flow | $54,891 | $232,607 | $-3,216 | $27,705 | $10,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,077 | -101,790 | -169,976 | 2,544 | -35,066 |
| Capital Expenditure | -41,646 | -190,956 | -177,823 | -123,576 | -45,793 |
| Free Cash Flow | -91,723 | -292,746 | -347,799 | -121,032 | -80,859 |